Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism

Triglycerides and cardiovascular disease

Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419 · see citing works

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115 · see citing works

Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis

Hayhurst, G. P., Lee, Y.-H., Lambert, G., Ward, J. M., & Gonzalez, F. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1393-1403.2001 · Cited by 1,107 · see citing works

Lipoprotein lipase: structure, function, regulation, and role in disease

Mead, J. R., Irvine, S. A., & Ramji, D. P. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 929 · see citing works

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

Dewey, F. E., Gusarova, V., Dunbar, R. L., O’Dushlaine, C., Schurmann, C., Gottesman, O., McCarthy, S., Van Hout, C. V., Bruse, S., Dansky, H. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612790 · Cited by 885 · see citing works

The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function.

Segrest, J., Jones, M., Loof, H. D., Brouillette, C. G., Venkatachalapathi, Y. V., & Anantharamaiah, G. M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41536-6 · Cited by 868 · see citing works

CLEARING FACTOR, A HEPARIN-ACTIVATED LIPOPROTEIN LIPASE

Korn, E. D. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66011-9 · Cited by 858 · see citing works

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome

Adiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820 · see citing works

Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic Acid

Carlson, L. A., & Rosenhamer, G. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb15891.x · Cited by 685 · see citing works

A specific apoprotein activator for lipoprotein lipase

LaRosa, J. C., Levy, R. I., Herbert, P. N., Lux, S. E., & Fredrickson, D. S. (1970) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(70)90468-7 · Cited by 668 · see citing works

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

Hegele, R. A., Ginsberg, H. N., Chapman, M. J., Nordestgaard, B. G., Kuivenhoven, J. A., Averna, M., Borén, J., Bruckert, E., Catapano, A. L., Descamps, O. S., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70191-8 · Cited by 635 · see citing works

Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.

Beisiegel†, U., Weber, W., & Bengtsson-Olivecrona, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8342 · Cited by 626 · see citing works

Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-II

Breckenridge, W. C., Little, J. A., Steiner, G. A., Chow, A., & Poapst, M. E. (1978) · New England Journal of Medicine · doi:10.1056/nejm197806082982301 · Cited by 603 · see citing works

Cardiovascular and Metabolic Effects of <i>ANGPTL3</i> Antisense Oligonucleotides

Graham, M. J., Lee, R. G., Brandt, T. A., Tai, L.-J., Fu, W., Peralta, R., Yu, R., Hurh, E., Paz, E., McEvoy, B. W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701329 · Cited by 573 · see citing works

Physiological regulation of lipoprotein lipase

Kersten, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.03.013 · Cited by 548 · see citing works

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia

Gaudet, D., Alexander, V. J., Baker, B. F., Brisson, D., Tremblay, K., Singleton, W., Geary, R. S., Hughes, S. G., Viney, N. J., Graham, M. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1400283 · Cited by 528 · see citing works

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction

Jørgensen, A. B., Frikke-Schmidt, R., West, A. S., Grande, P., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs431 · Cited by 501 · see citing works

Plasma High-Density Lipoproteins

Tall, A. R., & SMALL, D. M. (1978) · New England Journal of Medicine · doi:10.1056/nejm197811302992207 · Cited by 500 · see citing works

Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein

Brown, W. V., & Baginsky, M. L. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80149-9 · Cited by 493 · see citing works

Targeting APOC3 in the familial chylomicronemia syndrome

Gaudet, D., Brisson, D., Tremblay, K., Alexander, V. J., Singleton, W., Hughes, S. G., Geary, R. S., Baker, B. F., Graham, M. J., Crooke, R. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400284 · Cited by 491 · see citing works

Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1 Plays a Critical Role in the Lipolytic Processing of Chylomicrons

Beigneux, A. P., Davies, B. S. J., Gin, P., Weinstein, M. M., Farber, E., Qiao, X., Peale, F. V., Jr., Bunting, S., Walzem, R. L., Wong, J. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.02.002 · Cited by 470 · see citing works

Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat.

Wu, A. L., & Windmueller, H. G. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50321-5 · Cited by 446 · see citing works

Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis

Shih, D. M., Xia, Y.-R., Wang, X.-P., Miller, E. R., Castellani, L. W., Subbanagounder, G., Cheroutre, H., Faull, K. F., Berliner, J. A., Witztum, J. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910376199 · Cited by 423 · see citing works

GPIHBP1 Is Responsible for the Entry of Lipoprotein Lipase into Capillaries

Davies, B. S. J., Beigneux, A. P., Barnes, R. H., Tu, Y., Gin, P., Weinstein, M. M., Nobumori, C., Nyrén, R., Goldberg, I. J., Olivecrona, G., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.016 · Cited by 362 · see citing works

Chylomicronaemia–current diagnosis and future therapies

Brahm, A. J., & Hegele, R. A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.26 · Cited by 356 · see citing works

The Role of Angiopoietin-Like Proteins in Angiogenesis and Metabolism

Hato, T., Tabata, M., & Oike, Y. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.10.003 · Cited by 351 · see citing works

Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance

Park, Y., & Harris, W. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200282-jlr200 · Cited by 348 · see citing works

Farnesoid X-Activated Receptor Induces Apolipoprotein C-II Transcription: a Molecular Mechanism Linking Plasma Triglyceride Levels to Bile Acids

Kast-Woelbern, H. R., Nguyen, C., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0712 · Cited by 337 · see citing works

Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: Relation to serum lipoproteins

Nikkilä, E. A., Taskinen, M., Rehunen, S., & Härkönen, M. (1978) · Metabolism · doi:10.1016/0026-0495(78)90288-3 · Cited by 334 · see citing works

Apolipoprotein Specificity for Lipid Efflux by the Human ABCAI Transporter

Remaley, A. T., Stonik, J. A., Demosky, S. J., Neufeld, E. B., Bocharov, A. V., Vishnyakova, T. G., Eggerman, T. L., Patterson, A. P., Duverger, N., Santamarina-Fojo, S., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4219 · Cited by 327 · see citing works

Regulation of the synthesis, processing and translocation of lipoprotein lipase

Braun, J. E., & Severson, D. L. (1992) · Biochemical Journal · doi:10.1042/bj2870337 · Cited by 320 · see citing works

Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.

Sehayek, E., & Eisenberg, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55263-7 · Cited by 283 · see citing works

A Liver-Enriched Long Non-Coding RNA, lncLSTR, Regulates Systemic Lipid Metabolism in Mice

Li, P., Ruan, X., Yang, L., Kiesewetter, K., Zhao, Y. C., Luo, H., Chen, Y., Guček, M., Zhu, J., & Cao, H. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.004 · Cited by 280 · see citing works

Contributions of Different Fatty Acid Sources to Very Low-Density Lipoprotein-Triacylglycerol in the Fasted and Fed States

Barrows, B. R., & Parks, E. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1709 · Cited by 273 · see citing works

High-Abundance Polypeptides of the Human Plasma Proteome Comprising the Top 4 Logs of Polypeptide Abundance

Hortin, G. L., Sviridov, D. O., & Anderson, N. L. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.108175 · Cited by 270 · see citing works

Intracellular Trafficking and Secretion of VLDL

Tiwari, S., & Siddiqi, S. A. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241471 · Cited by 257 · see citing works

Regulated Expression of the Apolipoprotein E/C-I/C-IV/C-II Gene Cluster in Murine and Human Macrophages

Mak, P. A., Laffitte, B. A., Desrumaux, C. M., Joseph, S. B., Curtiss, L. K., Mangelsdorf, D. J., Tontonoz, P., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202993200 · Cited by 244 · see citing works

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease

Toth, P. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s104369 · Cited by 237 · see citing works

Untitled work

(2001) · Medical Entomology and Zoology · Cited by 227 · see citing works

Further Characterization of Apolipoproteins from the Human Plasma Very Low Density Lipoproteins

Brown, W. V., Levy, R. I., & Fredrickson, D. S. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62574-8 · Cited by 214 · see citing works

Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages

Zannis, V. I., Cole, F. S., Jackson, C. L., Kurnit, D. M., & Karathanasis, S. K. (1985) · Biochemistry · doi:10.1021/bi00337a028 · Cited by 203 · see citing works

Lipoprotein lipase: physiology, biochemistry, and molecular biology

Ira, J. G. (2001) · Frontiers in bioscience · doi:10.2741/goldberg · Cited by 195 · see citing works

Regulation of triglyceride metabolism by Angiopoietin-like proteins

Mattijssen, F., & Kersten, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.010 · Cited by 180 · see citing works

Current prospects of type II interferon γ signaling and autoimmunity

Green, D. S., Young, H. A., & Valencia, J. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.774745 · Cited by 171 · see citing works

Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets

Larsson, M., Vorrsjö, E., Talmud, P. J., Lõokene, A., & Olivecrona, G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.495366 · Cited by 169 · see citing works

Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II.

Kinnunen, P. K. J., Jackson, R. L., Smith, L. C., Gotto, A. M., & Sparrow, J. T. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4848 · Cited by 167 · see citing works

The Challenges and Promise of Targeting the Liver X Receptors for Treatment of Inflammatory Disease

Fessler, M. (2017) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2017.07.010 · Cited by 160 · see citing works

The GPIHBP1–LPL Complex Is Responsible for the Margination of Triglyceride-Rich Lipoproteins in Capillaries

Goulbourne, C. N., Gin, P., Tatar, A., Nobumori, C., Hoenger, A., Jiang, H., Grovenor, C. R. M., Adeyo, O., Esko, J. D., Goldberg, I. J., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.017 · Cited by 153 · see citing works

Absorption of the n − 3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans

Nordøy, A., Barstad, L., CONNOR, W. E., & Hatcher, L. F. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.5.1185 · Cited by 152 · see citing works

Alterations in levels and interrelations of plasma apolipoproteins induced by diet

Schonfeld, G., Weidman, S. W., Witztum, J. L., & Bowen, R. M. (1976) · Metabolism · doi:10.1016/0026-0495(76)90084-6 · Cited by 152 · see citing works

Identification of circulating apolipoproteins synthesized by rat small intestine in vivo.

Wu, A. L., & Windmueller, H. G. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40852-0 · Cited by 150 · see citing works

Two Distal Downstream Enhancers Direct Expression of the Human Apolipoprotein E Gene to Astrocytes in the Brain

Grehan, S., Tse, E., & Taylor, J. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00812.2001 · Cited by 138 · see citing works

Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL

Berbée, J. F. P., van der Hoogt, C. C., Sundararaman, D., Havekes, L. M., & Rensen, P. C. N. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400301-jlr200 · Cited by 137 · see citing works

Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice

Jong, M. C., Rensen, P. C. N., Dahlmans, V. E. H., van der Boom, H., van Berkel, T. J. C., & Havekes, L. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32211-2 · Cited by 136 · see citing works

A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease

Kei, A. A., Filippatos, T. D., Tsimihodimos, V., & Elisaf, M. S. (2012) · Metabolism · doi:10.1016/j.metabol.2011.12.002 · Cited by 136 · see citing works

Liver X receptors at the intersection of lipid metabolism and atherogenesis

Lee, S. D., & Tontonoz, P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.042 · Cited by 133 · see citing works

Apolipoprotein A-V-heparin Interactions

Lõokene, A., Beckstead, J. A., Nilsson, S., Olivecrona, G., & Ryan, R. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501589200 · Cited by 130 · see citing works

Diagnostic algorithm for familial chylomicronemia syndrome

Stroes, E., Moulin, P., Parhofer, K. G., Rebours, V., Löhr, J.-M., & Averna, M. (2017) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2016.10.002 · Cited by 130 · see citing works

National lipid association annual summary of clinical lipidology 2016

Bays, H. E., Jones, P. H., Orringer, C. E., Brown, W. V., & Jacobson, T. A. (2016) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.08.002 · Cited by 128 · see citing works

Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus

Reichlin, M., Fesmire, J., Quintero‐Del‐Rio, A. I., & Wolfson‐Reichlin, M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10624 · Cited by 127 · see citing works

Update on the molecular biology of dyslipidemias

Ramasamy, I. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.033 · Cited by 126 · see citing works

Drug-Induced Lipid Changes

Mantel-Teeuwisse, A. K., Kloosterman, J. M. E., der Zee, A. H. M., Klungel, O. H., Porsius, A. J., & de Boer, A. (2001) · Drug Safety · doi:10.2165/00002018-200124060-00003 · Cited by 126 · see citing works

LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias

Johansen, C. T., Dubé, J. B., Loyzer, M. N., MacDonald, A., Carter, D. E., McIntyre, A. D., Cao, H., Wang, J., Robinson, J. F., & Hegele, R. A. (2014) · Journal of Lipid Research · doi:10.1194/jlr.d045963 · Cited by 125 · see citing works

The ER-Associated Degradation Adaptor Protein Sel1L Regulates LPL Secretion and Lipid Metabolism

Sha, H., Sun, S., Francisco, A. B., Ehrhardt, N., Xue, Z., Liu, L., Lawrence, P., Mattijssen, F., Guber, R. D., Panhwar, M. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.015 · Cited by 124 · see citing works

Human Hepatic and Lipoprotein Lipase: The Loop Covering the Catalytic Site Mediates Lipase Substrate Specificity

Dugi, K. A., Dichek, H. L., & Santamarina-Fojo, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25396 · Cited by 121 · see citing works

Two Hepatic Enhancers, HCR.1 and HCR.2, Coordinate the Liver Expression of the Entire Human Apolipoprotein E/C-I/C-IV/C-II Gene Cluster

Allan, C. M., Taylor, S., & Taylor, J. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29113 · Cited by 106 · see citing works

Diagnosis and Management of Type I and Type V Hyperlipoproteinemia

Gotoda, T., Shirai, K., Ohta, T., Kobayashi, J., Yokoyama, S., Oikawa, S., Bujo, H., Ishibashi, S., Arai, H., Yamashita, S., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10702 · Cited by 99 · see citing works

The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain

Mysling, S., Kristensen, K. K., Larsson, M., Beigneux, A. P., Gårdsvoll, H., Fong, L. G., Bensadoun, A., Jørgensen, T. J. D., Young, S. G., & Ploug, M. (2016) · eLife · doi:10.7554/elife.12095 · Cited by 98 · see citing works

Excess of Rare Variants in Non–Genome-Wide Association Study Candidate Genes in Patients With Hypertriglyceridemia

Johansen, C. T., Wang, J., McIntyre, A. D., Martins, R. A., Ban, M. R., Lanktree, M. B., Huff, M. W., Péterfy, M., Mehrabian, M., Lusis, A. J., et al. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.960864 · Cited by 93 · see citing works

Apolipoprotein Localization in Isolated Drusen and Retinal Apolipoprotein Gene Expression

Li, C., Clark, M. E., Chimento, M. F., & Curcio, C. A. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1446 · Cited by 93 · see citing works

Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue

Ekman, R., & Nilsson‐Ehle, P. (1975) · Clinica Chimica Acta · doi:10.1016/0009-8981(75)90374-5 · Cited by 91 · see citing works

Partnership of PGC-1α and HNF4α in the Regulation of Lipoprotein Metabolism

Rhee, J., Ge, H., Yang, W., Fan, M., Handschin, C., Cooper, M. P., Lin, J. D., Li, C., & Spiegelman, B. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512636200 · Cited by 86 · see citing works

The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons.

Gin, P., Yin, L., Davies, B. S. J., Weinstein, M. M., Ryan, R. O., Bensadoun, A., Fong, L. G., Young, S. G., & Beigneux, A. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802579200 · Cited by 85 · see citing works

From fatty-acid sensing to chylomicron synthesis: Role of intestinal lipid-binding proteins

Buttet, M., Traynard, V., Tran, T. T. T., Besnard, P., Poirier, H., & Niot, I. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.011 · Cited by 84 · see citing works

A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.

de Graaf, J., Couture, P., & Sniderman, A. (2008) · Nature Clinical Practice Endocrinology &amp; Metabolism · doi:10.1038/ncpendmet0982 · Cited by 80 · see citing works

Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans

Gonzales, J. C., Gordts, P. L. S. M., Foley, E. M., & Esko, J. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67398 · Cited by 79 · see citing works

Lipoproteins and Apolipoproteins during the Progression of Chronic Renal Disease

Grützmacher, P., März, W., Peschke, B., Gross, W., & Schoeppe, W. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000185138 · Cited by 75 · see citing works

Monogenic pediatric dyslipidemias: Classification, genetics and clinical spectrum

Rahalkar, A. R., & Hegele, R. A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.10.007 · Cited by 74 · see citing works

Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity

Takahashi, M., Yagyu, H., Tazoe, F., Nagashima, S., Ohshiro, T., Okada, K., Osuga, J.-I., Goldberg, I. J., & Ishibashi, S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035568 · Cited by 72 · see citing works

NMR Structure of Human Apolipoprotein C-II in the Presence of Sodium Dodecyl Sulfate

MacRaild, C. A., Hatters, D. M., Howlett, G. J., & Gooley, P. R. (2001) · Biochemistry · doi:10.1021/bi002821m · Cited by 71 · see citing works

Therapeutic plasmapheresis for hypertriglyceridemia-associated acute pancreatitis: case series and review of the literature

Joglekar, K., Brannick, B., Kadaria, D., & Sodhi, A. (2017) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018817695449 · Cited by 66 · see citing works

Evolutionary Duplication of a Hepatic Control Region in the Human Apolipoprotein E Gene Locus

Allan, C. M., Walker, D. W., & Taylor, J. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26278 · Cited by 64 · see citing works

Hypertriglyceridemia: phenomics and genomics

Hegele, R. A., & Pollex, R. L. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-0005-1 · Cited by 60 · see citing works

New and emerging regulators of intestinal lipoprotein secretion

Xiao, C., Dash, S., Morgantini, C., & Lewis, G. F. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.047 · Cited by 59 · see citing works

Localization of a liver-specific enhancer in the apolipoprotein E/C-I/C-II gene locus

Shachter, N. S., Zhu, Y., Walsh, A., Breslow, J. L., & Smith, J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35732-1 · Cited by 59 · see citing works

Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide

Sakurai, T., Sakurai, A., Vaisman, B. L., Amar, M. J., Liu, C., Gordon, S. M., Drake, S. K., Pryor, M., Sampson, M. L., Yang, L., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.229740 · Cited by 58 · see citing works

Global Structure and Dynamics of Human Apolipoprotein CII in Complex with Micelles: Evidence for Increased Mobility of the Helix Involved in the Activation of Lipoprotein Lipase,

Zdunek, J., Martinez, G. V., Schleucher, J., Lycksell, P.-O., Yin, Y., Nilsson, S. K., Shen, Y., Olivecrona, G., & Wijmenga, S. S. (2003) · Biochemistry · doi:10.1021/bi0267184 · Cited by 56 · see citing works

Subdomain Chimeras of Hepatic Lipase and Lipoprotein Lipase

Hill, J. S., Yang, D. D., Nikazy, J., Curtiss, L. K., Sparrow, J. T., & Wong, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.30979 · Cited by 53 · see citing works

Functional Analyses of Human Apolipoprotein CII by Site-directed Mutagenesis

Shen, Y., Lõokene, A., Nilsson, S., & Olivecrona, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105421200 · Cited by 51 · see citing works

A Novel Apolipoprotein C-II Mimetic Peptide That Activates Lipoprotein Lipase and Decreases Serum Triglycerides in Apolipoprotein E–Knockout Mice

Amar, M. J., Sakurai, T., Sakurai-Ikuta, A., Sviridov, D. O., Freeman, L. A., Ahsan, L., & Remaley, A. T. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220418 · Cited by 50 · see citing works

Mobility of “HSPG-bound” LPL explains how LPL is able to reach GPIHBP1 on capillaries

Allan, C. M., Larsson, M., Jung, R. S., Ploug, M., Bensadoun, A., Beigneux, A. P., Fong, L. G., & Young, S. G. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m072520 · Cited by 48 · see citing works

Activation of lipoprotein lipase by native and acylated peptides of apolipoprotein C-II

Musliner, T. A., Herbert, P. N., & Church, E. C. (1979) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(79)90224-8 · Cited by 47 · see citing works

Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III, and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level

Sakurabayashi, I., Saito, Y., Kita, T., Matsuzawa, Y., & Goto, Y. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00591-5 · Cited by 46 · see citing works

Deregulated Lipid Sensing by Intestinal CD36 in Diet-Induced Hyperinsulinemic Obese Mouse Model

Buttet, M., Poirier, H., Traynard, V., Kévin, G., Tran, T. T. T., Sundaresan, S., Besnard, P., Abumrad, N. A., & Niot, I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145626 · Cited by 45 · see citing works

A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis

Ueda, M., Dunbar, R. L., Wolska, A. T., Sikora, T. U., Escobar, M. D. R., Seliktar, N., deGoma, E. M., DerOhannessian, S. L., Morrell, L., McIntyre, A. D., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3903 · Cited by 44 · see citing works

The role of CREB-H transcription factor in triglyceride metabolism

Lee, A. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283508fed · Cited by 40 · see citing works

Developmental and Pharmacological Regulation of Apolipoprotein C-II Gene Expression

Andersson, Y., Majd, Z., Lefebvre, A., Martin, G., Sechkin, A. V., Kosykh, V., Fruchart, J., Najïb, J., & Staels, B. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.115 · Cited by 39 · see citing works

Post-Heparin LPL Activity Measurement Using VLDL As a Substrate: A New Robust Method for Routine Assessment of Plasma Triglyceride Lipolysis Defects

Filippo, M. D., Marçais, C., Charrière, S., Marmontel, O., Broyer, M., Delay, M., Merlin, M., Nollace, A., Valéro, R., Lagarde, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096482 · Cited by 36 · see citing works

Transactivation of the Human Apolipoprotein CII Promoter by Orphan and Ligand-dependent Nuclear Receptors

Kardassis, D., Sacharidou, E., & Zannis, V. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17810 · Cited by 35 · see citing works

A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II

Meyers, N. L., Larsson, M., Olivecrona, G., & SMALL, D. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.629865 · Cited by 34 · see citing works

Parallel increase of plasma apoproteins C‐II and C‐III in Type 2 diabetic patients

Béliard, S., Nogueira, J. P., Maraninchi, M., Lairon, D., Nicolay, A., Giral, P., Portugal, H., Vialettes, B., & Valéro, R. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02757.x · Cited by 34 · see citing works

Macrophage-specific up-regulation of apolipoprotein E gene expression by STAT1 is achieved via long range genomic interactions

Trusca, V. G., Fuior, E. V., Florea, I. C., Kardassis, D., Simionescu, M., & Gafencu, A. V. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179572 · Cited by 33 · see citing works

Identification of a Lipoprotein Lipase Cofactor-binding Site by Chemical Cross-linking and Transfer of Apolipoprotein C-II-responsive Lipolysis from Lipoprotein Lipase to Hepatic Lipase

McIlhargey, T. L., Yang, Y., Wong, H., & Hill, J. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300315200 · Cited by 31 · see citing works

Apolipoprotein A-I, A-II, C-II, and H expression in the developing lung and sex difference in surfactant lipids

Provost, P. R., Boucher, É. L., & Tremblay, Y. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0238 · Cited by 31 · see citing works

A Short Proximal Promoter and the Distal Hepatic Control Region-1 (HCR-1) Contribute to the Liver Specificity of the Human Apolipoprotein C-II Gene

Vorgia, P., Zannis, V. I., & Kardassis, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4188 · Cited by 27 · see citing works

Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids

Kardassis, D., Roussou, A., Papakosta, P., Boulias, K., Talianidis, I., & Zannis, V. I. (2003) · Biochemical Journal · doi:10.1042/bj20021532 · Cited by 23 · see citing works

Autoimmune Severe Hypertriglyceridemia Induced by Anti-Apolipoprotein C-II Antibody

Yamamoto, H., Tanaka, M., Yoshiga, S., Funahashi, T., Shimomura, I., & Kihara, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3619 · Cited by 23 · see citing works

The effect of maternal undernutrition on the rat placental transcriptome: protein restriction up-regulates cholesterol transport

Daniel, Z. C. T. R., Swali, A., Emes, R. D., & Langley‐Evans, S. C. (2016) · Genes & Nutrition · doi:10.1186/s12263-016-0541-3 · Cited by 23 · see citing works

Site-directed Mutagenesis of Apolipoprotein CII to Probe the Role of Its Secondary Structure for Activation of Lipoprotein Lipase

Shen, Y. H., Lõokene, A., Zhang, L., & Olivecrona, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022046 · Cited by 22 · see citing works

A single nucleotide substitution in the promoter region of the apolipoprotein C-II gene identified in individuals with chylomicronemia

Streicher, R., Geisel, J., Weisshaar, C., Avci, H., Oette, K., Müller‐Wieland, D., & Krone, W. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37463-0 · Cited by 21 · see citing works

Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E

Millar, J. S., Lassman, M. E., Thomas, T. A., Ramakrishnan, R., Jumes, P. A., Dunbar, R. L., deGoma, E. M., Baer, A. L., Karmally, W., Donovan, D. S., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m074880 · Cited by 21 · see citing works

Tgif1 represses apolipoprotein gene expression in liver

Melhuish, T. A., Chung, D. D., Bjerke, G. A., & Wotton, D. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22713 · Cited by 20 · see citing works

Expression of the apolipoprotein C-II gene during myelomonocytic differentiation of human leukemic cells

Chun, E. M., Park, Y. J., Kang, H. S., Cho, H. M., Jun, D. Y., & Kim, Y. H. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.645 · Cited by 19 · see citing works

Molecular Genetics of ApoC-II and Lipoprotein Lipase Deficiency

Fojo, S. S., Gennes, J. L. D., Beisiegel†, U., Baggio, G., Stalenhoef, A. F. H., Brunzell, J. D., & Brewer, H. B. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5904-3_40 · Cited by 16 · see citing works

Mass determination of major plasma proteins by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

Hortin, G. L., & Remaley, A. T. (2006) · Clinical Proteomics · doi:10.1385/cp:2:1:103 · Cited by 14 · see citing works

Residents' Exposure to Educational Experiences in Facilitating Hospital Discharges

Young, E., Stickrath, C. R., McNulty, M. C., Calderon, A. J., Chapman, E. N., Gonzalo, J. D., Kuperman, E. F., Lopez, M., Smith, C. J., Sweigart, J. R., et al. (2017) · Journal of Graduate Medical Education · doi:10.4300/jgme-d-16-00503.1 · Cited by 14 · see citing works

Triglyceride‐rich lipoprotein metabolism in women: roles of apoC‐ II and apoC‐ III

Ooi, E. M. M., Chan, D. C., Hodson, L., Adiels, M., Borén, J., Karpe, F., Fielding, B. A., Watts, G. F., & Barrett, P. H. R. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12657 · Cited by 12 · see citing works

Apolipoprotein C-II deficiency: detection of immunoreactive apolipoprotein C-II in the intestinal mucosa of two patients

Capurso, A., Mogavero, A. M., Resta, F., Tommaso, M. D., Taverniti, P., Turturro, F., Rosa, M. L., Marcovina, S. M., & Catapano, A. L. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38495-9 · Cited by 12 · see citing works

STAT1 Interacts with RXRα to Upregulate ApoCII Gene Expression in Macrophages

Trusca, V. G., Albulescu, I. C., Kardassis, D., & Gafencu, A. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040463 · Cited by 10 · see citing works

Elevated expression of four apolipoprotein genes during the 32–35week gestation window in the human developing lung

Provost, P. R., & Tremblay, Y. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.06.013 · Cited by 9 · see citing works

Apolipoprotein C-II and lipoprotein lipase show a temporal and geographic correlation with surfactant lipid synthesis in preparation for birth

Côté, M., Provost, P. R., Gérard-Hudon, M.-C., & Tremblay, Y. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-111 · Cited by 5 · see citing works

Structure of the human apolipoprotein C-II gene promoter.

Streicher, R., Avci, H., Munck, M., Siemeister, G., Geisel, J., Weisshaar, C., Müller‐Wieland, D., & Krone, W. (1996) · PubMed · Cited by 2 · see citing works

Clinical review on triglycerides

Laufs, U., Parhofer, K. G., Ginsberg, H. N., & Hegele, R. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz785 · Cited by 544 · see citing works

A Modern Approach to Dyslipidemia

Berberich, A. J., & Hegele, R. A. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab037 · Cited by 502 · see citing works

Multi-organ proteomic landscape of COVID-19 autopsies

Nie, X., Qian, L.-J., Sun, R., Huang, B., Dong, X., Xiao, Q., Zhang, Q.-S., Lu, T., Yue, L., Chen, S., et al. (2020) · medRxiv · doi:10.1016/j.cell.2021.01.004 · Cited by 373 · see citing works

Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia

Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00676-y · Cited by 315 · see citing works

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

Pradhan, A. D., Paynter, N. P., Everett, B. M., Glynn, R. J., Amarenco, P., Elam, M., Ginsberg, H., Hiatt, W. R., Ishibashi, S., Koenig, W., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.09.011 · Cited by 319 · see citing works

Apolipoproteins in vascular biology and atherosclerotic disease

Mehta, A., & Shapiro, M. D. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00613-5 · Cited by 273 · see citing works

Genetics of hypertriglyceridemia

Dron, J. S., & Hegele, R. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00455 · Cited by 244 · see citing works

Lipoprotein lipase and its regulators: an unfolding story

Wu, S. A., Kersten, S., & Qi, L. (2021) · Trends in Endocrinology &amp; Metabolism · doi:10.1016/j.tem.2020.11.005 · Cited by 225 · see citing works

Lipid and Lipoprotein Metabolism

Feingold, K. R. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.02.008 · Cited by 198 · see citing works

Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024

Bays, H. E., Kirkpatrick, C. F., Maki, K. C., Toth, P. P., Morgan, R. T., Tondt, J., Christensen, S. M., Dixon, D. L., & Jacobson, T. A. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.04.001 · Cited by 190 · see citing works

Lipid-Lowering Agents: Targets Beyond PCSK9

Hegele, R. A., & Tsimikas, S. (2019) · Circulation Research · doi:10.1161/circresaha.118.313171 · Cited by 171 · see citing works

Apolipoprotein C‐II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway

Wang, C., Yang, Z., Xu, E., Shen, X., Wang, X., Li, Z., Heng, Y., Chen, K., Hu, Q., Xia, X., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.522 · Cited by 147 · see citing works

Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease

Benito‐Vicente, A., Uribe, K. B., Jebari‐Benslaiman, S., Galicia-García, U., Ostolaza, H., & Martı́n, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113426 · Cited by 135 · see citing works

Endothelial Cell Receptors in Tissue Lipid Uptake and Metabolism

Abumrad, N. A., Cabodevilla, A. G., Samovski, D., Pietka, T., Basu, D., & Goldberg, I. J. (2021) · Circulation Research · doi:10.1161/circresaha.120.318003 · Cited by 125 · see citing works

The Antioxidant Properties of Selenium and Vitamin E; Their Role in Periparturient Dairy Cattle Health Regulation

Xiao, J., Khan, M. Z., Ma, Y., Alugongo, G. M., Ma, J., Chen, T., Khan, A. A., & Cao, Z. (2021) · Antioxidants · doi:10.3390/antiox10101555 · Cited by 124 · see citing works

Lipophagy and Lipolysis Status in Lipid Storage and Lipid Metabolism Diseases

Kłoska, A., Węsierska, M., Malinowska, M., Gabig‐Cimińska, M., & Jakóbkiewicz‐Banecka, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176113 · Cited by 108 · see citing works

Lactylated Apolipoprotein C‐II Induces Immunotherapy Resistance by Promoting Extracellular Lipolysis

Chen, J., Zhao, D., Wang, Y., Liu, M., Zhang, Y., Feng, T., Xiao, C., Huan, S., Miao, R., Xu, L. N., et al. (2024) · Advanced Science · doi:10.1002/advs.202406333 · Cited by 110 · see citing works

Omega-3 polyunsaturated fatty acids: anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease

Shibabaw, T. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03965-7 · Cited by 108 · see citing works

Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024

Bays, H. E., Kirkpatrick, C. F., Maki, K. C., Toth, P. P., Morgan, R. T., Tondt, J., Christensen, S. M., Dixon, D. L., & Jacobson, T. A. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100108 · Cited by 101 · see citing works

Integrated analysis of behavioral, epigenetic, and gut microbiome analyses in AppNL-G-F, AppNL-F, and wild type mice

Kundu, P., Torres, E. R. S., Stagaman, K., Kasschau, K., Okhovat, M., Holden, S., Ward, S., Nevonen, K. A., Davis, B. A., Saito, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83851-4 · Cited by 75 · see citing works

GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia

Shade, L. M. P., Katsumata, Y., Abner, E. L., Aung, K. Z., Claas, S. A., Qiao, Q., Heberle, B. A., Brandon, J. A., Page, M. L., Hohman, T. J., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01939-9 · Cited by 72 · see citing works

A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides

Wolska, A. T., Lo, L., Sviridov, D. O., Pourmousa, M., Pryor, M., Ghosh, S. S., Kakkar, R. K., Davidson, M., Wilson, S. R., Pastor, R. W., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw7905 · Cited by 69 · see citing works

Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes

D’Erasmo, L., Costanzo, A. D., Cassandra, F., Minicocci, I., Polito, L., Montali, A., Ceci, F., & Arca, M. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313401 · Cited by 69 · see citing works

Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases

Wolska, A. T., Reimund, M., Sviridov, D. O., Amar, M. J., & Remaley, A. T. (2021) · Cells · doi:10.3390/cells10030597 · Cited by 62 · see citing works

Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance

Packard, C. J., Pirillo, A., Tsimikas, S., Ference, B. A., & Catapano, A. L. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad177 · Cited by 65 · see citing works

Apolipoprotein C-II: the re-emergence of a forgotten factor

Wolska, A. T., Reimund, M., & Remaley, A. T. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000680 · Cited by 54 · see citing works

Apolipoproteins: New players in cancers

He, Y., Chen, J., Ma, Y., & Chen, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1051280 · Cited by 52 · see citing works

Lipidomic Approaches to Study HDL Metabolism in Patients with Central Obesity Diagnosed with Metabolic Syndrome

Mocciaro, G., D’Amore, S., Jenkins, B., Kay, R. G., Murgia, A., Herrera-Marcos, L. V., Neun, S., Sowton, A. P., Hall, Z., Palma-Duran, S. A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126786 · Cited by 51 · see citing works

The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions

Zwartjes, M. S. Z., Gerdes, V. E. A., & Nieuwdorp, M. (2021) · Metabolites · doi:10.3390/metabo11080531 · Cited by 50 · see citing works

Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models

Basu, D., & Bornfeldt, K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00504 · Cited by 51 · see citing works

Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia

Boiko, A. S., Mednova, I. A., Kornetova, E. G., Semke, A. V., Bokhan, N. A., LOONEN, A. J. M., & Ivanova, S. А. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02033 · Cited by 49 · see citing works

Hypertriglyceridemia: new approaches in management and treatment

Wolska, A. T., Yang, Z., & Remaley, A. T. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000710 · Cited by 50 · see citing works

IL-10/STAT3 is reduced in childhood obesity with hypertriglyceridemia and is related to triglyceride level in diet-induced obese rats

Liu, Y., Xu, D., Yin, C., Wang, S., Wang, M., & Xiao, Y. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0265-z · Cited by 46 · see citing works

Current Diagnosis and Management of Primary Chylomicronemia

Okazaki, H., Gotoda, T., Ogura, M., Ishibashi, S., Inagaki, K., Daida, H., Hayashi, T., Hori, M., Masuda, D., Matsuki, K., et al. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17054 · Cited by 44 · see citing works

Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders

Turri, M., Marchi, C., Adorni, M. P., Calabresi, L., & Zimetti, F. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159123 · Cited by 54 · see citing works

The Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase Activity

Wen, Y., Chen, Y., & Konrad, R. J. (2022) · Advanced Biology · doi:10.1002/adbi.202200093 · Cited by 43 · see citing works

The Role of Apolipoproteins in the Commonest Cancers: A Review

Darwish, N. M., Al‐Hail, M., Mohamed, Y. H., Al-Saady, R., Mohsen, S., Zar, A., Al-Mansoori, L., & Pedersen, S. (2023) · Cancers · doi:10.3390/cancers15235565 · Cited by 40 · see citing works

Quartet of APOCs and the Different Roles They Play in Diabetes

Hsu, C.-C., Kanter, J. E., Kothari, V. M., & Bornfeldt, K. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318290 · Cited by 37 · see citing works

Preeclampsia Affects Lipid Metabolism and HDL Function in Mothers and Their Offspring

Stadler, J. T., Scharnagl, H., Wadsack, C., & Marsche, G. (2023) · Antioxidants · doi:10.3390/antiox12040795 · Cited by 39 · see citing works

Diagnostic and prognostic significance of mRNA expressions of apolipoprotein A and C family genes in hepatitis B virus‐related hepatocellular carcinoma

Wang, X., Gong, Y., Deng, T., Zhang, L., Liao, X., Han, C., Yang, C., Huang, J., Wang, Q., Song, X., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29131 · Cited by 38 · see citing works

Apolipoprotein C2 - CD36 Promotes Leukemia Growth and Presents a Targetable Axis in Acute Myeloid Leukemia

Zhang, T., Yang, J., Vaikari, V. P., Beckford, J., Wu, S. K., Akhtari, M., & Alachkar, H. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-19-0077 · Cited by 38 · see citing works

APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups

Goyal, S., Tanigawa, Y., Zhang, W., Chai, J. F., Almeida, M., Sim, X., Lerner, M. R., Chainakul, J., Ramiu, J. G., Seraphin, C., et al. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01531-8 · Cited by 39 · see citing works

Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells

Burger, F., Baptista, D., Roth, A., Brandt, K. J., da Silva, R., Montecucco, F., Mach, F., & Miteva, K. (2022) · Cells · doi:10.3390/cells11030411 · Cited by 37 · see citing works

Synthesis of Fructose Biosensors and Progressing Their Efficiency Using Californium Colloidal Nanoparticles for Detecting Fructose and Triglycerides

Heidari, A. (2020) · Advanced Science Engineering and Medicine · doi:10.1166/asem.2020.2635 · Cited by 36 · see citing works

ApoC2 deficiency elicits severe hypertriglyceridemia and spontaneous atherosclerosis: A rodent model rescued from neonatal death

Gao, M., Yang, C., Wang, X., Guo, M., Liu, Y., Gao, S., Zhang, X., Ruan, G., Li, X., Tian, W., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154296 · Cited by 36 · see citing works

Recent Application of Zebrafish Models in Atherosclerosis Research

Tang, D., Geng, F., Yu, C., & Zhang, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.643697 · Cited by 36 · see citing works

Safety and efficacy of therapies for chylomicronemia

Shamsudeen, I., & Hegele, R. A. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2094768 · Cited by 37 · see citing works

Dyslipidemias in clinical practice

Cabezas, M. C., Burggraaf, B., & Klop, B. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.09.010 · Cited by 36 · see citing works

The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage

Jin, N., Matter, W. F., Michael, L. F., Qian, Y., Gheyi, T., Cano, L., Perez, C. A., Lafuente, C., Broughton, H. B., & Espada, A. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00954 · Cited by 34 · see citing works

Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia

Paragh, G., Németh, Á., Harangi, M., Banach, M., & Fülöp, P. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01631-z · Cited by 34 · see citing works

A nexus of lipid and O-Glcnac metabolism in physiology and disease

Lockridge, A. D., & Hanover, J. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.943576 · Cited by 32 · see citing works

Rapid reduction in triglyceride levels by therapeutic plasma exchange in patients with hypertriglyceridemic pancreatitis

Chen, Z., Huang, X., Zhang, M., Han, N., & Ning, Y. (2021) · Journal of Clinical Apheresis · doi:10.1002/jca.21954 · Cited by 34 · see citing works

Extracellular vesicles and lipoproteins – Smart messengers of blood cells in the circulation

Nguyen, P. H. D., Le, A. H., Pek, J. S. Q., Pham, T. T., Jayasinghe, M. K., Do, D. V., Phung, C. D., & Le, M. T. N. (2022) · Journal of Extracellular Biology · doi:10.1002/jex2.49 · Cited by 31 · see citing works

Disorders of Lipid Metabolism

Masood, S., Masood, O., Mujtaba, S. F., & Banerjee, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-4723-8_4 · Cited by 31 · see citing works

Alzheimer Disease: Recent Updates on Apolipoprotein E and Gut Microbiome Mediation of Oxidative Stress, and Prospective Interventional Agents

Botchway, B. O., Okoye, F. C., Chen, Y., Arthur, W. E., & Fang, M. (2022) · Aging and disease · doi:10.14336/ad.2021.0616 · Cited by 32 · see citing works

Understanding Hypertriglyceridemia: Integrating Genetic Insights

Alves, M., Laranjeira, F., & Correia‐da‐Silva, G. (2024) · Genes · doi:10.3390/genes15020190 · Cited by 33 · see citing works

ApoPred: Identification of Apolipoproteins and Their Subfamilies With Multifarious Features

Liu, T., Chen, J., Zhang, D., Zhang, Q., Peng, B., Xu, L., & Tang, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.621144 · Cited by 29 · see citing works

A new phenotypic classification system for dyslipidemias based on the standard lipid panel

Sampson, M. L., Ballout, R. A., Soffer, D. E., Wolska, A. T., Wilson, S. R., Meeusen, J. W., Donato, L. J., Fatica, E. M., Otvos, J. D., Brinton, E. A., et al. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01585-8 · Cited by 29 · see citing works

The associations between exercise and lipid biomarkers

Sulague, R. M., Suan, N. M., Mendoza, M. F., & Lavie, C. J. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.11.004 · Cited by 30 · see citing works

Stoichiometric constraints for detection of EV‐borne biomarkers in blood

Zarovni, N., Mladenović, D., Brambilla, D., Panico, F., & Chiari, M. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70034 · Cited by 27 · see citing works

Transient hypertriglyceridemia: a common finding during Epstein-Barr virus-induced infectious mononucleosis

Páez-Guillán, E., Franco, J. C., Alende, R., Garitaonaindía, Y., & González‐Quintela, A. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01603-9 · Cited by 27 · see citing works

Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies

Vyletelová, V., Nováková, M., & Pašková, Ľ. (2022) · Pharmaceuticals · doi:10.3390/ph15101278 · Cited by 28 · see citing works

Apolipoproteins as potential communicators play an essential role in the pathogenesis and treatment of early atherosclerosis

Yang, L., Luo, X., Hua, Z., Xue, X., Wang, X., Pang, M., Wang, T., Lü, A., & Liu, Y. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.86475 · Cited by 28 · see citing works

Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk

Zhou, Y., Mägi, R., Milani, L. A., & Lauschke, V. M. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p086710 · Cited by 26 · see citing works

Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans

Hieronimus, B., Griffen, S. C., Keim, N. L., Bremer, A. A., Berglund, L., Nakajima, K., Havel, P. J., & Stanhope, K. L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070913 · Cited by 26 · see citing works

Inverse effects of APOC2 and ANGPTL4 on the conformational dynamics of lid-anchoring structures in lipoprotein lipase

Kumari, A., Grønnemose, A. L., Kristensen, K. K., Winther, A.-M. L., Young, S. G., Jørgensen, T. J. D., & Ploug, M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221888120 · Cited by 24 · see citing works

Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?

Cole, J., Zubirán, R., Wolska, A. T., Jialal, I., & Remaley, A. T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175737 · Cited by 23 · see citing works

Cholesterol transport and beyond: Illuminating the versatile functions of HDL apolipoproteins through structural insights and functional implications

Bhale, A. S., Meilhac, O., d’Hellencourt, C. L., Vijayalakshmi, M. A., & Venkataraman, K. (2024) · BioFactors · doi:10.1002/biof.2057 · Cited by 24 · see citing works

Gain and loss events in the evolution of the apolipoprotein family in vertebrata

Liu, J.-Q., Li, W., Zheng, J., Tian, Q.-N., Huang, J., & Dai, S. (2019) · BMC Evolutionary Biology · doi:10.1186/s12862-019-1519-8 · Cited by 22 · see citing works

Genetic Variants at the APOE Locus Predict Cardiometabolic Traits and Metabolic Syndrome: A Taiwan Biobank Study

Yeh, K.-H., Wan, H., Teng, M., Chou, H., Hsu, L., & Ko, Y. (2022) · Genes · doi:10.3390/genes13081366 · Cited by 22 · see citing works

Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation

Silbernagel, G., Chen, Y., Rief, M., Kleber, M. E., Hoffmann, M. M., Stojaković, T., Stang, A., Sarzynski, M. A., Bouchard, C., März, W., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad261 · Cited by 22 · see citing works

Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease

Shang, R., & Rodrigues, B. B. (2024) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2024.13199 · Cited by 21 · see citing works

FADS2 inhibition in essential fatty acid deficiency induces hepatic lipid accumulation via impairment of very low-density lipoprotein (VLDL) secretion

Hayashi, Y., Shimamura, A., Ishikawa, T., Fujiwara, Y., & Ichi, I. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.064 · Cited by 21 · see citing works

The Impact of Acute Nutritional Interventions on the Plasma Proteome

Vernardis, S. I., Demichev, V., Lemke, O., Grüning, N., Messner, C. B., White, M. E. H., Pietzner, M., Peluso, A., Collet, T., Henning, E., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad031 · Cited by 20 · see citing works

Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer’s disease

Hu, Y., Meuret, C. J., Martinez, A., Yassine, H. N., & Nedelkov, D. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000919 · Cited by 20 · see citing works

Mining the plasma-proteome associated genes in patients with gastro-esophageal cancers for biomarker discovery

Vizeacoumar, F. S., Guo, H., Dwernychuk, L., Zaidi, A., Freywald, A., Wu, F., Vizeacoumar, F. J., & Ahmed, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-87037-w · Cited by 19 · see citing works

Decoding the role of angiopoietin-like protein 4/8 complex–mediated plasmin generation in the regulation of LPL activity

Chen, Y., Zhen, Y., Russell, A. M., Ehsani, M. E., Siegel, R. W., Qian, Y., & Konrad, R. J. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100441 · Cited by 19 · see citing works

Quantitative Proteomic Analysis of Plasma after Remote Ischemic Conditioning in a Rhesus Monkey Ischemic Stroke Model

Song, S., Guo, L., Wu, D., Shi, J., Duan, Y., He, X., Liu, Y., Ding, Y., Ji, X., & Meng, R. (2021) · Biomolecules · doi:10.3390/biom11081164 · Cited by 19 · see citing works

Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice

Komatsu, T., Sakurai, T., Wolska, A. T., Amar, M. J., Sakurai, A., Vaisman, B. L., Sviridov, D. O., Demosky, S. J., Pryor, M., Ikewaki, K., et al. (2019) · Journal of Nutrition and Metabolism · doi:10.1155/2019/7078241 · Cited by 18 · see citing works

Application of enzymatic fluorometric assays to quantify phosphatidylcholine, phosphatidylethanolamine and sphingomyelin in human plasma lipoproteins

Tsuji, T., Yuri, T., Terada, T., & Morita, S. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105102 · Cited by 17 · see citing works

Fatal attractions that trigger inflammation and drive atherosclerotic disease

Sharma, H., Mossman, K. L., & Austin, R. C. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14169 · Cited by 17 · see citing works

Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach

Reimund, M., Wolska, A. T., Risti, R., Wilson, S. R., Sviridov, D. O., Remaley, A. T., & Lõokene, A. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.130 · Cited by 17 · see citing works

Liver-specific knockout of B cell lymphoma 6 suppresses progression of non-alcoholic steatohepatitis in mice

Chikada, H., Ida, K., Nishikawa, Y., Inagaki, Y., & Kamiya, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-66539-z · Cited by 17 · see citing works

Lipoprotein Lipase: Structure, Function, and Genetic Variation

Perera, S. D., Wang, J., McIntyre, A. D., & Hegele, R. A. (2025) · Genes · doi:10.3390/genes16010055 · Cited by 16 · see citing works

Role of glycosylphosphatidylinositol‐anchored high‐density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes

Kurooka, N., Eguchi, J., & Wada, J. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14056 · Cited by 17 · see citing works

An overview of persistent chylomicronemia: much more than meets the eye

Larouche, M., Watts, G. F., Ballantyne, C. M., & Gaudet, D. (2025) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000903 · Cited by 17 · see citing works

AAV-Mediated ApoC2 Gene Therapy: Reversal of Severe Hypertriglyceridemia and Rescue of Neonatal Death in ApoC2-Deficient Hamsters

Yang, C., Tian, W., Ma, S., Guo, M., Lin, X., Gao, F., Dong, X., Gao, M., Wang, Y., Liu, C., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.07.011 · Cited by 15 · see citing works

Kaempferitrin-Treated HepG2 Differentially Expressed Exosomal Markers and Affect Extracellular Vesicle Sizes in the Secretome

Ku, W., Sridharan, B., Chen, J., Li, J.-Y., Yang, S.-Y., & Lee, M. (2021) · Biomolecules · doi:10.3390/biom11020187 · Cited by 16 · see citing works

Modelling the Impact of Chronic Cigarette Smoke Exposure in Obese Mice: Metabolic, Pulmonary, Intestinal, and Cardiac Issues

Rémy, G., Dubois‐Deruy, E., Alard, J., Kervoaze, G., Chwastyniak, M., Baron, M., Beury, D., Siegwald, L., Caboche, S., Hot, D., et al. (2020) · Nutrients · doi:10.3390/nu12030827 · Cited by 15 · see citing works

Proteomic studies on apoB-containing lipoprotein in cardiovascular research: A comprehensive review.

Gianazza, E., Zoanni, B., Mallia, A., Brioschi, M., Colombo, G., & Banfi, C. (2021) · Mass spectrometry reviews (Print) · doi:10.1002/mas.21747 · Cited by 10 · see citing works

Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Bril, F., Berg, G. A., Barchuk, M., & Nogueira, J. P. (2025) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2025.14.1.5 · Cited by 15 · see citing works

Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the larger HDL3 from very low-density lipoprotein (VLDL)

Yamazaki, A., Ohkawa, R., Yamagata, Y., Horiuchi, Y., Lai, S.-J., Kameda, T., Ichimura, N., Tohda, S., & Tozuka, M. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0288 · Cited by 14 · see citing works

Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays

Oldham, D., Wang, H., Mullen, J., Lietzke, E. E., Sprenger, K. G., Reigan, P., Eckel, R. H., & Bruce, K. D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.926631 · Cited by 14 · see citing works

Nutritional Treatment of Hypertriglyceridemia in Childhood: From Healthy-Heart Counselling to Life-Saving Diet

Capra, M. E., Biasucci, G., Banderali, G., & Pederiva, C. (2023) · Nutrients · doi:10.3390/nu15051088 · Cited by 13 · see citing works

Hypertriglyceridemia: molecular and genetic landscapes

Scicchitano, P., Amati, F., Ciccone, M. M., D’Ascenzi, F., Imbalzano, E., Liga, R., Paolillo, S., Pastore, M. C., Rinaldi, A., Mattioli, A. V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126364 · Cited by 13 · see citing works

Integrating Proteomics and Lipidomics for Evaluating the Risk of Breast Cancer Progression: A Pilot Study

Starodubtseva, N. L., Tokareva, A., Родионов, В. В., Brzhozovskiy, A. G., Bugrova, A. E., Chagovets, V., Кометова, В. В., Kukaev, E., Soares, N. C., Kovalev, G. I., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11071786 · Cited by 13 · see citing works

PLA2G12A protects against diet‐induced obesity and insulin resistance by enhancing energy expenditure and clearance of circulating triglycerides

Wu, M., Wang, Q., Li, H., Tao, J., Wang, Z., Zhang, S., Chen, L., Li, P., Chen, L., & Qu, L. (2024) · The FASEB Journal · doi:10.1096/fj.202302075r · Cited by 12 · see citing works

Increased plasma apoM levels impair triglyceride turnover in mice

Hajny, S., Borup, A., Elsøe, S., & Christoffersen, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158969 · Cited by 12 · see citing works

The Effects of Exercise on Lipid Biomarkers

Mendoza, M. F., Kachur, S. M., & Lavie, C. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1558-4_6 · Cited by 12 · see citing works

Genetically-engineered hamster models: applications and perspective in dyslipidemia and atherosclerosis-related cardiovascular disease

Liu, G., Lai, P., Guo, J., Wang, Y.-H., & Xian, X. (2021) · Medical Review · doi:10.1515/mr-2021-0004 · Cited by 11 · see citing works

Apolipoprotein C-II: the re-emergence of a forgotten factor

Wolska, A. T., Reimund, M., & Remaley, A. T. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000680 · Cited by 54 · see citing works

Abstract 498: A Novel Human APOC2 Mutation Causes Severe Hypertriglyceridemia Due to Decreased Fractional Clearance Rates of Very Low Density Lipoprotein apoB and Triglyceride and Increased Production Rates of Very Low Density Lipoprotein Triglyceride

Reyes‐Soffer, G., Matveyenko, A., Seid, H., Ngai, C. I., Thomas, T., Holleran, S., Ramakrishnan, R., & Ginsberg, H. N. (2019) · Arteriosclerosis Thrombosis and Vascular Biology

The role of high density lipoprotein apolipoprotein CII in triglyceride metabolism

Kashyap, M. L., Srivastava, L., Hynd, B. A., Perisutti, G., Brady, D., Gartside, P. S., & Glueck, C. J. (1978) · Lipids · doi:10.1007/bf02533853 · Cited by 24 · see citing works

Apolipoprotein C-II Deficiency with No Rare Variant in the APOC2 Gene

Takase, S., Osuga, J.-I., Fujita, H., Hara, K., Sekiya, M., Igarashi, M., Takanashi, M., Takeuchi, Y., Izumida, Y., Ohta, K., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.16592 · Cited by 7 · see citing works

Molecular Genetics of ApoC-II and Lipoprotein Lipase Deficiency

Fojo, S. S., Gennes, J. L. D., Beisiegel†, U., Baggio, G., Stalenhoef, A. F. H., Brunzell, J. D., & Brewer, H. B. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5904-3_40 · Cited by 16 · see citing works